Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024(Status and Outlook)

Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024(Status and Outlook)



Report Overview:

BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.

The Global BCG Vaccine for Tuberculosis (TB) Market Size was estimated at USD 397.17 million in 2023 and is projected to reach USD 550.75 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.

This report provides a deep insight into the global BCG Vaccine for Tuberculosis (TB) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG Vaccine for Tuberculosis (TB) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG Vaccine for Tuberculosis (TB) market in any manner.

Global BCG Vaccine for Tuberculosis (TB) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Sanofi Pasteur

Japan BCG Lab

China National Biotec

AJ Vaccines

Serum Institute of India

Intervax

GSBPL

Statens Serum Institute

Biomed Lublin

ANLIS Malbran

Fundação Ataulpho de Paiva

BB-NCIPD

Taj Pharmaceuticals

Bio Farma

Microgen

Torlakinstitut

Institut Pasteur de Tunis

IVAC

Market Segmentation (by Type)

Immune Type

Therapy Type

Market Segmentation (by Application)

Hospitals

Clinics

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the BCG Vaccine for Tuberculosis (TB) Market

Overview of the regional outlook of the BCG Vaccine for Tuberculosis (TB) Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG Vaccine for Tuberculosis (TB) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of BCG Vaccine for Tuberculosis (TB)
1.2 Key Market Segments
1.2.1 BCG Vaccine for Tuberculosis (TB) Segment by Type
1.2.2 BCG Vaccine for Tuberculosis (TB) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BCG Vaccine for Tuberculosis (TB) Market Overview
2.1 Global Market Overview
2.1.1 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BCG Vaccine for Tuberculosis (TB) Market Competitive Landscape
3.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Manufacturers (2019-2024)
3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2019-2024)
3.3 BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites, Area Served, Product Type
3.6 BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
3.6.1 BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
3.6.2 Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
4.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of BCG Vaccine for Tuberculosis (TB) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BCG Vaccine for Tuberculosis (TB) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
6.3 Global BCG Vaccine for Tuberculosis (TB) Market Size Market Share by Type (2019-2024)
6.4 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2019-2024)
7 BCG Vaccine for Tuberculosis (TB) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BCG Vaccine for Tuberculosis (TB) Market Sales by Application (2019-2024)
7.3 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Application (2019-2024)
7.4 Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
8 BCG Vaccine for Tuberculosis (TB) Market Segmentation by Region
8.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region
8.2 North America
8.2.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck BCG Vaccine for Tuberculosis (TB) Basic Information
9.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Overview
9.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
9.2.2 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
9.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.2.4 Sanofi Pasteur Business Overview
9.2.5 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.2.6 Sanofi Pasteur Recent Developments
9.3 Japan BCG Lab
9.3.1 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
9.3.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
9.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.3.5 Japan BCG Lab Business Overview
9.3.6 Japan BCG Lab Recent Developments
9.4 China National Biotec
9.4.1 China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
9.4.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
9.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.4.4 China National Biotec Business Overview
9.4.5 China National Biotec Recent Developments
9.5 AJ Vaccines
9.5.1 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
9.5.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
9.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.5.4 AJ Vaccines Business Overview
9.5.5 AJ Vaccines Recent Developments
9.6 Serum Institute of India
9.6.1 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
9.6.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
9.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.6.4 Serum Institute of India Business Overview
9.6.5 Serum Institute of India Recent Developments
9.7 Intervax
9.7.1 Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
9.7.2 Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
9.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.7.4 Intervax Business Overview
9.7.5 Intervax Recent Developments
9.8 GSBPL
9.8.1 GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
9.8.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
9.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.8.4 GSBPL Business Overview
9.8.5 GSBPL Recent Developments
9.9 Statens Serum Institute
9.9.1 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
9.9.2 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
9.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.9.4 Statens Serum Institute Business Overview
9.9.5 Statens Serum Institute Recent Developments
9.10 Biomed Lublin
9.10.1 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
9.10.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
9.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.10.4 Biomed Lublin Business Overview
9.10.5 Biomed Lublin Recent Developments
9.11 ANLIS Malbran
9.11.1 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
9.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
9.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.11.4 ANLIS Malbran Business Overview
9.11.5 ANLIS Malbran Recent Developments
9.12 Fundação Ataulpho de Paiva
9.12.1 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
9.12.2 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
9.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.12.4 Fundação Ataulpho de Paiva Business Overview
9.12.5 Fundação Ataulpho de Paiva Recent Developments
9.13 BB-NCIPD
9.13.1 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
9.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
9.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.13.4 BB-NCIPD Business Overview
9.13.5 BB-NCIPD Recent Developments
9.14 Taj Pharmaceuticals
9.14.1 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
9.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
9.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.14.4 Taj Pharmaceuticals Business Overview
9.14.5 Taj Pharmaceuticals Recent Developments
9.15 Bio Farma
9.15.1 Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
9.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
9.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.15.4 Bio Farma Business Overview
9.15.5 Bio Farma Recent Developments
9.16 Microgen
9.16.1 Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
9.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
9.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.16.4 Microgen Business Overview
9.16.5 Microgen Recent Developments
9.17 Torlakinstitut
9.17.1 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
9.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
9.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.17.4 Torlakinstitut Business Overview
9.17.5 Torlakinstitut Recent Developments
9.18 Institut Pasteur de Tunis
9.18.1 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
9.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
9.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.18.4 Institut Pasteur de Tunis Business Overview
9.18.5 Institut Pasteur de Tunis Recent Developments
9.19 IVAC
9.19.1 IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
9.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
9.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.19.4 IVAC Business Overview
9.19.5 IVAC Recent Developments
10 BCG Vaccine for Tuberculosis (TB) Market Forecast by Region
10.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast
10.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
10.2.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region
10.2.4 South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of BCG Vaccine for Tuberculosis (TB) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Type (2025-2030)
11.1.2 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of BCG Vaccine for Tuberculosis (TB) by Type (2025-2030)
11.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Application (2025-2030)
11.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) Forecast by Application
11.2.2 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings